PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine-DIMED, University of Padova, Italy; Department of Laboratory Medicine, University-Hospital of Padova, Italy.\', \'Department of Surgical Oncological and Gastroenterological Sciences - DISCOG, University of Padova, Italy; Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.\', \'Emergency Department, Padua University Hospital, Padua, Italy.\', \'Infective and Tropical Disease Unit, Padua University Hospital, Padua, Italy.\', \'Department of Laboratory Medicine, University-Hospital of Padova, Italy.\', \'Department of Medicine-DIMED, University of Padova, Italy; Department of Laboratory Medicine, University-Hospital of Padova, Italy. Electronic address: mario.plebani@unipd.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0009-8981(21)00129-710.1016/j.cca.2021.04.006
?:doi
?:hasPublicationType
?:journal
  • Clinica chimica acta; international journal of clinical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 33857476
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all